ECOG-ACRIN EAY131-P

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol P: EAY131-P: Phase II Study of PI3K Beta Specific Inhibitor, GSK2636771, in Patients with Tumors with PTEN Loss by IHC

(See required screening study ECOG-ACRIN EAY131)

NCT#02465060

Effective immediately, 06/15/18, EAY131-P is formally closed to accrual, as it has reached its enrollment goal.